TAO

LOE Approaching

troleandomycin

NDAORALCAPSULE
Approved
May 1969
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
2

Clinical Trials (2)

NCT04111978Phase 3Recruiting

MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO)

Started Nov 2020
540 enrolled
Ovarian Neoplasm EpithelialFallopian Tube NeoplasmsPeritoneal Neoplasms+3 more
NCT03390218N/AUnknown

TAO Outpatient Trial for Anxiety and Depression

Started Jan 2018
300 enrolled
Anxiety DisordersDepression
Data Sources
  • Drug label: DailyMed / FDA
  • Clinical trials: ClinicalTrials.gov
  • Patent data: FDA Orange Book
  • Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.